Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC.
Level 5 - mechanism / opinion, no new human data
In vitro bench mechanistic research without human clinical data
PubMed 31034780 · doi:10.1096/fj.201802418R
What was done
Researchers investigated the mechanism by which SARS-CoV and its accessory protein ORF3a trigger inflammatory pathways using in vitro molecular assays. They examined pro-IL-1β transcription, NF-κB signaling, IL-1β maturation and secretion, protein colocalization, ASC speck formation, and TRAF3-dependent ubiquitination of p105 and ASC in cell models.
What was found
The abstract reports molecular mechanisms and pathways qualitatively without specific numerical data or effect sizes: - SARS-CoV and ORF3a activated pro-IL-1β gene transcription through NF-κB, mediated by TRAF3-dependent ubiquitination and processing of p105. - ORF3a-induced IL-1β secretion required NLRP3, ASC, and TRAF3, but was independent of ORF3a ion channel activity or AIM2. - ORF3a colocalized and interacted with TRAF3 and ASC in cytoplasmic punctate structures, facilitating ASC speck formation. - K63-linked ubiquitination of ASC was more pronounced during SARS-CoV infection or ORF3a expression and was TRAF3-dependent.
Why it matters
The findings identify a specific molecular pathway connecting the SARS-CoV ORF3a accessory protein to NLRP3 inflammasome activation and cytokine production, outlining potential targets for intervening in coronavirus-mediated inflammatory responses.
Limits
The study is restricted to in vitro bench experiments and lacks in vivo animal or clinical human validation. The abstract provides no quantitative values, sample sizes, or statistical confidence intervals.
Cited by
- contradicts SARS-CoV-1 activates the NLRP3 inflammasome, triggering NF-κB and a cytokine storm in the lungs.